BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37815566)

  • 1. A Multilevel Primary Care Intervention to Improve Follow-Up of Overdue Abnormal Cancer Screening Test Results: A Cluster Randomized Clinical Trial.
    Atlas SJ; Tosteson ANA; Wright A; Orav EJ; Burdick TE; Zhao W; Hort SJ; Wint AJ; Smith RE; Chang FY; Aman DG; Thillaiyapillai M; Diamond CJ; Zhou L; Haas JS
    JAMA; 2023 Oct; 330(14):1348-1358. PubMed ID: 37815566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilevel Follow-up of Cancer Screening (mFOCUS): Protocol for a multilevel intervention to improve the follow-up of abnormal cancer screening test results.
    Haas JS; Atlas SJ; Wright A; Orav EJ; Aman DG; Breslau ES; Burdick TE; Carpenter E; Chang F; Dang T; Diamond CJ; Feldman S; Harris KA; Hort SJ; Housman ML; Mecker A; Lehman CD; Percac-Lima S; Smith R; Wint AJ; Yang J; Zhou L; Tosteson ANA
    Contemp Clin Trials; 2021 Oct; 109():106533. PubMed ID: 34375748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial.
    Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ
    JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mailed Letter Versus Phone Call to Increase Uptake of Cancer Screening: A Pragmatic, Randomized Trial.
    Kiran T; Davie S; Moineddin R; Lofters A
    J Am Board Fam Med; 2018; 31(6):857-868. PubMed ID: 30413542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial.
    Winer RL; Lin J; Anderson ML; Tiro JA; Green BB; Gao H; Meenan RT; Hansen K; Sparks A; Buist DSM
    JAMA; 2023 Nov; 330(20):1971-1981. PubMed ID: 38015219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial.
    Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM
    JAMA Netw Open; 2019 Nov; 2(11):e1914729. PubMed ID: 31693128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
    Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
    JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Combined Patient Decision Aid and Patient Navigation vs Usual Care for Colorectal Cancer Screening in a Vulnerable Patient Population: A Randomized Clinical Trial.
    Reuland DS; Brenner AT; Hoffman R; McWilliams A; Rhyne RL; Getrich C; Tapp H; Weaver MA; Callan D; Cubillos L; Urquieta de Hernandez B; Pignone MP
    JAMA Intern Med; 2017 Jul; 177(7):967-974. PubMed ID: 28505217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis.
    Dougherty MK; Brenner AT; Crockett SD; Gupta S; Wheeler SB; Coker-Schwimmer M; Cubillos L; Malo T; Reuland DS
    JAMA Intern Med; 2018 Dec; 178(12):1645-1658. PubMed ID: 30326005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial.
    Green BB; Wang CY; Anderson ML; Chubak J; Meenan RT; Vernon SW; Fuller S
    Ann Intern Med; 2013 Mar; 158(5 Pt 1):301-11. PubMed ID: 23460053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of four outreach modalities to patients overdue for cervical cancer screening in the primary care setting: a randomized trial.
    Peitzmeier SM; Khullar K; Potter J
    Cancer Causes Control; 2016 Sep; 27(9):1081-91. PubMed ID: 27447961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Care Practitioner Perceptions on the Follow-up of Abnormal Cancer Screening Test Results.
    Atlas SJ; Tosteson ANA; Burdick TE; Wright A; Breslau ES; Dang TH; Wint AJ; Smith RE; Harris KA; Zhou L; Haas JS
    JAMA Netw Open; 2022 Sep; 5(9):e2234194. PubMed ID: 36173627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-visit-based cancer screening using a novel population management system.
    Atlas SJ; Zai AH; Ashburner JM; Chang Y; Percac-Lima S; Levy DE; Chueh HC; Grant RW
    J Am Board Fam Med; 2014; 27(4):474-85. PubMed ID: 25002002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mailed FIT (fecal immunochemical test), navigation or patient reminders? Using microsimulation to inform selection of interventions to increase colorectal cancer screening in Medicaid enrollees.
    Davis MM; Nambiar S; Mayorga ME; Sullivan E; Hicklin K; O'Leary MC; Dillon K; Hassmiller Lich K; Gu Y; Lind BK; Wheeler SB
    Prev Med; 2019 Dec; 129S():105836. PubMed ID: 31635848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve adherence to colorectal cancer screening among patients cared for in a community health center.
    Baker DW; Brown T; Buchanan DR; Weil J; Cameron KA; Ranalli L; Ferreira MR; Stephens Q; Balsley K; Goldman SN; Wolf MS
    BMC Health Serv Res; 2013 Apr; 13():153. PubMed ID: 23627550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial.
    Rat C; Pogu C; Le Donné D; Latour C; Bianco G; Nanin F; Cowppli-Bony A; Gaultier A; Nguyen JM
    JAMA; 2017 Sep; 318(9):816-824. PubMed ID: 28873160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.